Placental insufficiency has a significant genetic component, though it is not caused by a single inherited gene. Research estimates that roughly 30% to 50% of the variation in how well a placenta supports fetal growth can be traced to genetic factors from both the mother and the baby. The condition affects up to 15% of pregnancies worldwide when you count its related complications: fetal growth restriction, preeclampsia, preterm labor, and stillbirth.
If you’re asking this question because you or a family member experienced placental insufficiency, the short answer is that family history does raise your risk, but genetics is only one piece of a complex puzzle that also includes blood pressure, immune function, and environmental exposures.
How Strong Is the Hereditary Link?
The earliest large-scale study on this topic, from 1951, analyzed over 1,700 sibling groups and estimated that nearly 50% of the variation in birth weight (a key marker of placental function) was attributable to shared genetic factors. A more recent analysis of over 100,000 families in Norway put the contribution of fetal genetics specifically at about 31% of birth weight variation. That gap between the two numbers reflects the difficulty of separating genetic influence from shared environment, but both studies point to a substantial inherited component.
The family connection is especially well documented for preeclampsia, one of the most common consequences of poor placental function. Hospital record reviews dating back to the 1960s found that daughters or granddaughters of women who had preeclampsia were two to eight times more likely to develop the condition themselves compared to women with no family history. That’s a meaningful increase in risk, and it holds up across multiple generations.
Both Parents Contribute Genetic Risk
One of the more surprising findings in placental research is that the father’s genes play a disproportionately large role in how the placenta develops. Landmark experiments in the 1980s demonstrated that the sperm and egg make unequal contributions to early development: the paternal genetic contribution primarily drives the growth and differentiation of the placenta itself, while the maternal contribution has more influence over the embryo’s body.
This happens through a process called genomic imprinting, where certain genes are active only when inherited from one parent and silenced when inherited from the other. A small but critical set of these imprinted genes controls placental development, nutrient transfer, and growth signaling. When the dosage or function of these genes is disrupted, the placenta may not form or function properly.
Recent clinical evidence suggests that paternally inherited imprints may be less stable than maternal ones, meaning they’re more vulnerable to disruption. Multiple aspects of paternal health, including environmental exposures and lifestyle factors, can alter the epigenetic regulation of these imprinted genes in sperm, which then affects how the placenta develops. This means a father’s health history and exposures matter for placental function in ways that weren’t appreciated until recently.
Chromosomal Errors in the Placenta
Sometimes the genetic issue isn’t inherited at all but arises spontaneously during early cell division. A condition called confined placental mosaicism occurs when the placenta contains cells with an abnormal number of chromosomes while the fetus itself is chromosomally normal. This mismatch can impair placental efficiency even though the baby’s own genetics are fine.
In a study of 215 cases of confined placental mosaicism detected in the first trimester, 34% of the pregnancies showed fetal growth restriction, and 23% resulted in a birth weight below the 10th percentile. These rates were elevated regardless of which specific chromosome was affected or which cell layer of the placenta carried the abnormality. The takeaway is that random chromosomal errors confined to the placenta are a meaningful, non-inherited cause of placental insufficiency.
Specific Genes Under Investigation
Researchers have identified several genes that appear to influence placental function and birth weight. Large-scale genome studies have pinpointed regions of DNA where common variations correlate with birth weight differences, and follow-up work by the National Institute of Child Health and Human Development has traced some of these signals to specific genes active in placental tissue. These genes are involved in cell growth, protein processing, and signaling pathways that help the placenta establish and maintain blood flow to the fetus.
No single gene has been identified as “the cause” of placental insufficiency. Instead, the genetic architecture looks like many other complex conditions: dozens or possibly hundreds of small-effect gene variants combine with each other and with environmental factors to push risk up or down. This is why genetic testing can’t currently predict placental insufficiency the way it can for single-gene disorders.
Genetics Can Influence Treatment Response
One practical consequence of the genetic component involves how well preventive treatments work. Low-dose aspirin is commonly recommended for women at high risk of preeclampsia, but it doesn’t work equally well for everyone. An ongoing clinical trial is investigating whether a specific genetic variant in the PAR4 receptor on platelets explains some of this inconsistency. The variant, which affects how platelets respond to aspirin, is found in roughly 65% of Black women compared to about 20% of non-Black women. This may partly explain the higher rates of aspirin failure in preventing preeclampsia among Black women, and it illustrates how genetic background can shape not just risk but also treatment effectiveness.
Recurrence Risk in Future Pregnancies
For women who have experienced placental insufficiency, the risk of it happening again depends heavily on the underlying cause. One rare immune-related placental condition called chronic histiocytic intervillositis carries a recurrence rate between 25% and 100%, making it one of the most predictable forms. More common presentations of placental insufficiency have lower but still elevated recurrence rates compared to the general population, particularly when the original case was severe or occurred early in pregnancy.
The combination of genetic predisposition and a prior episode means that women with a family history and a personal history of placental problems face compounding risk factors. Monitoring in subsequent pregnancies typically involves more frequent ultrasounds to track fetal growth and blood flow through the placenta, which can catch declining function before it leads to serious complications.
What This Means for Your Risk
If your mother, sister, or grandmother experienced preeclampsia, fetal growth restriction, or stillbirth related to placental problems, your own risk is elevated but far from certain. The genetic contribution is real, accounting for roughly a third of the variation, but that leaves two-thirds influenced by factors like blood pressure, body weight, immune function, infections, and exposures during pregnancy. Having a family history doesn’t guarantee problems, and lacking one doesn’t guarantee safety.
The paternal side matters too. If the father of the pregnancy has a family history of partners experiencing placental complications, that’s worth mentioning to a care provider, since the father’s genetic contribution to placental development is substantial. This is an area where awareness is still catching up to the science, and many people don’t think to consider the paternal family history at all.